• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 4. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzodioxoles Benzodioxoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzodioxoles

6-Bromo-3,4-methylenedioxybenzoic Acid (CAS No. 60546-62-5): A Comprehensive Overview

6-Bromo-3,4-methylenedioxybenzoic acid (CAS No. 60546-62-5) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, including a bromine atom and a methylenedioxy group, which contribute to its diverse chemical and biological properties. In this article, we will delve into the chemical structure, synthesis methods, biological activities, and potential applications of 6-Bromo-3,4-methylenedioxybenzoic acid.

Chemical Structure and Properties

6-Bromo-3,4-methylenedioxybenzoic acid is a substituted benzoic acid with the molecular formula C₉H₇BrO₄. The presence of the bromine atom at the 6-position and the methylenedioxy group at the 3,4-positions imparts unique chemical properties to this compound. The methylenedioxy group (OCH₂O) is known for its ability to form hydrogen bonds and participate in various chemical reactions, making it a valuable functional group in organic synthesis. The bromine atom, on the other hand, can be readily substituted in various reactions, providing flexibility in the synthesis of derivatives.

The physical properties of 6-Bromo-3,4-methylenedioxybenzoic acid include a melting point of approximately 180-182°C and a solubility profile that varies depending on the solvent. It is generally soluble in polar solvents such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF), but less soluble in non-polar solvents like hexane. These properties make it suitable for use in various chemical and biological assays.

Synthesis Methods

The synthesis of 6-Bromo-3,4-methylenedioxybenzoic acid can be achieved through several routes, each with its own advantages and limitations. One common method involves the bromination of 3,4-methylenedioxybenzoic acid using bromine or a brominating agent such as N-bromosuccinimide (NBS). This reaction typically proceeds under mild conditions and yields high purity products. Another approach involves the condensation of 3,4-methylenedioxyphenol with carbon dioxide in the presence of a catalyst, followed by bromination.

In recent years, green chemistry principles have been increasingly applied to the synthesis of organic compounds to reduce environmental impact. For example, microwave-assisted synthesis has been explored as an efficient and environmentally friendly method for preparing 6-Bromo-3,4-methylenedioxybenzoic acid. This technique not only reduces reaction times but also minimizes waste generation.

Biological Activities and Applications

6-Bromo-3,4-methylenedioxybenzoic acid has been studied for its potential biological activities and therapeutic applications. One area of significant interest is its anti-inflammatory properties. Research has shown that this compound can inhibit the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in vitro. These findings suggest that 6-Bromo-3,4-methylenedioxybenzoic acid may have potential as an anti-inflammatory agent for treating conditions such as arthritis and inflammatory bowel disease.

In addition to its anti-inflammatory effects, 6-Bromo-3,4-methylenedioxybenzoic acid has also been investigated for its anticancer properties. Studies have demonstrated that it can induce apoptosis in various cancer cell lines by modulating key signaling pathways such as p53 and Bcl-2. These findings highlight its potential as a lead compound for developing novel anticancer drugs.

The methylenedioxy group present in 6-Bromo-3,4-methylenedioxybenzoic acid has also been shown to enhance its bioavailability and pharmacokinetic properties. This makes it an attractive candidate for further optimization through structure-activity relationship (SAR) studies to improve its therapeutic efficacy.

Potential Therapeutic Applications

The diverse biological activities of 6-Bromo-3,4-methylenedioxybenzoic acid have led to its exploration in several therapeutic areas. In addition to its anti-inflammatory and anticancer properties, this compound has shown promise in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Preclinical studies have indicated that it can protect neurons from oxidative stress and prevent neuroinflammation.

Clinical trials are currently underway to evaluate the safety and efficacy of derivatives of 6-Bromo-3,4-methylenedioxybenzoic acid. These trials aim to determine optimal dosing regimens and identify any potential side effects. The results from these trials will provide valuable insights into the clinical utility of this compound.

Safety Considerations

Safety is a critical aspect when considering the use of any chemical compound in pharmaceutical applications. While no major safety concerns have been reported for 6-Bromo-3,4-methylenedioxybenzoic acid, it is important to conduct thorough toxicological studies to ensure its safety profile. Preclinical studies have shown that this compound is well-tolerated at therapeutic doses with minimal toxicity.

In conclusion, 6-Bromo-3,4-methylenedioxybenzoic acid (CAS No. 60546-62-5) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure confers diverse biological activities that make it an attractive candidate for further development as a therapeutic agent. Ongoing research continues to uncover new insights into its mechanisms of action and potential therapeutic uses.

• 24958-42-7(2-Bromo-5-benzyloxy-4-methoxybenzoic Acid)
• 15930-53-7(6-bromo-1,3-dioxaindane-5-carbaldehyde)
• 71568-87-1(2-bromo-3,4-dimethoxybenzoic acid)
• 121936-68-3(2-Bromo-5-hydroxy-4-methoxybenzoic acid)
• 6406-16-2(Naphtho[2,3-b]thiophene-3-ol,9-chloro-2-[3-(sulfooxy)benzo[b]thien-2-yl]-, 3-(hydrogen sulfate))
• 90050-65-0(2-bromo-4-hydroxy-5-methoxybenzoic acid)
• 81474-47-7(6-BROMO-7-METHOXY-BENZO[1,3]DIOXOLE-5-CARBOXYLIC ACID METHYL ESTER)
• 81474-46-6(Methyl 4-bromo-7-methoxybenzo[d][1,3]dioxole-5-carboxylate)
• 72744-56-0(5-Bromobenzo1,3dioxole-4-carboxylic Acid)
• 6286-46-0(2-Bromo-4,5-dimethoxybenzoic acid)